A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

NCT00270075 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Blood Transfusion
Blood Transfusion, Autologous
Orthopedic Procedures
Orthopedic Surgery
Cardiovascular Surgical Procedure

Interventions

DRUG: epoetin alfa

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.